Jazz Pharmaceuticals (JAZZ) Raw Materials (2010 - 2019)

Jazz Pharmaceuticals' Raw Materials history runs 10 years deep, the most recent figure standing at $7.1 million for Q1 2019.

• In Q1 2019, Raw Materials changed N/A year-over-year to $7.1 million; the TTM figure through Mar 2019 stood at $7.1 million (changed N/A YoY), while the FY2018 annual figure was $5.6 million, up 58.22% from the prior year.
• Raw Materials was $7.1 million for Q1 2019 at Jazz Pharmaceuticals, up from $5.6 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $7.1 million in Q1 2019 to a low of $1.5 million in Q4 2016.
• Historically, Raw Materials has averaged $3.6 million across 5 years, with a median of $2.7 million in 2016.
• The sharpest annual moves came in 2016 and 2017: Raw Materials slumped 40.68% in 2016, then soared 128.96% in 2017.
• A 5-year view of Raw Materials shows it stood at $2.6 million in 2015, then plunged by 40.68% to $1.5 million in 2016, then soared by 128.96% to $3.5 million in 2017, then surged by 58.22% to $5.6 million in 2018, then advanced by 27.37% to $7.1 million in 2019.
• The last three Raw Materials figures came in at $7.1 million (Q1 2019), $5.6 million (Q4 2018), and $4.2 million (Q2 2018), per Business Quant data.